We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Role of CETP inhibitors in cardiovascular risk reduction - Will lessons from the past lead to future success?
Stephen Nicholls, FRACP, FACC, FESC, FAHA
John Kastelein, MD, PhD
Roxana Mehran, MD
Unmet needs in lowering LDL-c
New insights on CETP inhibition from genetic research and clinical trials
Exploring the role of a novel CETP inhibitor in lipid management
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Gout Beyond the Joints: What’s the Hidden Danger?
Is Gout Hiding in the Nephrology Clinic?
Is Managing Gout in the Nephrology Clinic a Challenge?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
Can You Manage Patients With Uncontrolled Gout More Effectively?
What’s New About Gout? Nephrology Perspective
What’s New About Gout? Rheumatology Perspective
What Are the Emerging Therapies for Managing Gout?
Should We Look for Gout in the Cardiology Clinic?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education